In this episode, Drs. Christie Ballantyne and Anne Goldberg discuss updates on familial hypercholesterolemia (FH) diagnosis and management. Recent publications in January 2026 in the Journal of Clinical Lipidology and The Journal of Pediatrics address refined diagnostic criteria and special populations including children and pregnant women. In this podcast episode, Drs. Ballantyne and Goldberg discuss the importance of early detection, genetic testing, and treatment.

To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment, click here!

In this podcast, Drs. Michelle Kittleson and Jan Griffin provide a practical overview of evaluation and management of transthyretin amyloid cardiomyopathy (ATTR-CM) based on ACC's 2025 Concise Clinical Guidance document the Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. The experts elaborate on key takeaways, including identifying cardiac and extra-cardiac features that raise suspicion, outlining the diagnostic pathway and screening strategies, and utilizing current disease-modifying therapies and heart failure management. Guidance on monitoring, determining treatment candidacy, and emerging future therapies is also discussed.

This podcast is supported by an educational grant from BridgeBio.

ACC Chief Innovation Officer Dr. Ami Bhatt brings together Drs. Alexandre Almorad and Christopher Porterfield to discuss how advancements in pulsed field ablation (PFA) are transforming atrial fibrillation treatment. In this episode, the participants break down the latest research in PFA and explain what that means for the procedure's safety and effectiveness.

This podcast is supported by Johnson & Johnson.

Subscribe to CardiaCast